Safety of Topical Calcineurin Inhibitors in Atopic Blepharoconjunctivitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Long-Term Safety of Topical Pimecrolimus and Topical Tacrolimus in Atopic Blepharoconjunctivitis
JAMA Dermatol 2014 Feb 05;[EPub Ahead of Print], V Kiiski, A Remitz, S Reitamo, J Mandelin, O KariFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.